L-R Kathi Vidal, Benjamin Searle, Myrtha Hurtado Rivas, Carol Fang
5 June 2025NewsBig PharmaMuireann Bolger

‘Choose your IP armour carefully’: Novartis, HP, Nestlé and Vidal

Companies face increasingly complex decisions over what IP to use, particularly when collaborating. Muireann Bolger hears the dos and don’ts of protection from senior counsel.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Europe
4 June 2025   Survey launched ahead of LSIPR’s LSPN Europe conference | Seeks input on AI impact, Brexit, and Unitary Patent system | Focuses on patent challenges in pharma, biotech, medical devices, diagnostics to shape conference discussions in London.
Americas
9 May 2025   Counsel are using their unique position as the centre of science and law to deliver value far beyond traditional IP protection, finds Marisa Woutersen.
Americas
8 May 2025   Legal heads from Pfizer and The Broad Institute stress the need for cross-disciplinary teams and careful training as AI software becomes mainstream, reports Marisa Woutersen from LSPN 2025.

More on this story

Europe
4 June 2025   Survey launched ahead of LSIPR’s LSPN Europe conference | Seeks input on AI impact, Brexit, and Unitary Patent system | Focuses on patent challenges in pharma, biotech, medical devices, diagnostics to shape conference discussions in London.
Americas
9 May 2025   Counsel are using their unique position as the centre of science and law to deliver value far beyond traditional IP protection, finds Marisa Woutersen.
Americas
8 May 2025   Legal heads from Pfizer and The Broad Institute stress the need for cross-disciplinary teams and careful training as AI software becomes mainstream, reports Marisa Woutersen from LSPN 2025.

More on this story

Europe
4 June 2025   Survey launched ahead of LSIPR’s LSPN Europe conference | Seeks input on AI impact, Brexit, and Unitary Patent system | Focuses on patent challenges in pharma, biotech, medical devices, diagnostics to shape conference discussions in London.
Americas
9 May 2025   Counsel are using their unique position as the centre of science and law to deliver value far beyond traditional IP protection, finds Marisa Woutersen.
Americas
8 May 2025   Legal heads from Pfizer and The Broad Institute stress the need for cross-disciplinary teams and careful training as AI software becomes mainstream, reports Marisa Woutersen from LSPN 2025.